Table 1 Attribute characteristics for the discrete choice experiment
Attribute | Description | COM-B domain | Levels |
|---|---|---|---|
Patient communication | Speaking with patients about the risks and benefits of ADT | Capability–Psychological | In-person Virtual |
Multidisciplinary review | Consulting with colleagues (e.g., urologic oncologist, medical oncology) prior to the patient appointment, or not, to assist with de-implementation decisions regarding ADT overuse | Opportunity–Social (provider) | Yes No |
Documentation | Documenting ongoing ADT treatment decisions in a pharmacy order or a medical note | Opportunity–Physical | Pharmacy order Medical note |
Support tools | Support tools to aid with conversations to include provider talking points or patient education materials regarding ADT overuse | Opportunity–Social (patient support) | Provider talking points Patient education materials |